Media Bulletin

Schwartz wins PR accounts for three cancer treatment firms

By Staff

15th September 2010

Category: PR

Following on from its recent signing of melanoma vaccine client, Scancell, Schwartz Communications UK has signed three oncology accounts.

– UK-based Microsulis, which uses microwave technology to destroy previously inoperable tumours

– global health science company MDS Nordion which provides products and services used for the prevention, diagnosis and treatment of disease, specifically liver cancer treatments

– South Korea-based KAEL-GemVax, which is developing new cancer vaccines to enhance survival while maintaining a high quality of life for patients

[lnk|http://www.schwartzcomm.com|_blank|Schwartz Communications UK Limited]

Links for media database subscribers

Not a media database subscriber?

No links attached.

Related news

2nd December 2016 PR

Global Fintech PR Network launched

2nd December 2016 PR

Nexus chooses W for the White House’s greetings card

29th November 2016 PR

Hatch Communications welcomes three members to the team

New! Check out our Media Jobs board for PR and Journalism vacancies Learn more